NegotiumBio supports Pharmaceutical and Biotechnology innovators programs across all modalities - small and large molecule, cell and gene therapies. We have unique direct experience in leading engagement negotiations for outsourced manufacturing with CAR-T, TCR, viral vector, and CRISPR based therapies.
Relevant transaction and negotiation experience includes – but is not limited – to the following:
Outsourced Manufacturing Protein Purification
Identification of novel manufacturing options to RFP assessments
NPV = $30+M
Market research, full assessment of capacities, budget and timelines
Enabled our client to engage with players beyond their classic circle of suppliers
Enabled some suppliers to engage with a new industry.